Shanxi C&Y Pharmaceutical Group Co Ltd (300254) — Financial Flexibility Index
Shanxi C&Y Pharmaceutical Group Co Ltd (300254) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of CN¥63.30 Million (operating CF CN¥52.93 Million minus capex CN¥10.37 Million) represents 0% of total liabilities (CN¥972.67 Million). Also explore Shanxi C&Y Pharmaceutical Group Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanxi C&Y Pharmaceutical Group Co Ltd Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for Shanxi C&Y Pharmaceutical Group Co Ltd across 17 annual periods. Check Shanxi C&Y Pharmaceutical Group Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Shanxi C&Y Pharmaceutical Group Co Ltd (2008–2024)
Year-by-year free cash flow to debt coverage for Shanxi C&Y Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see 300254 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.13x | CN¥122.44 Million | CN¥70.94 Million | CN¥949.55 Million | ▲ +17.7% |
| 2023 | 0.11x | CN¥71.73 Million | CN¥37.81 Million | CN¥654.64 Million | ▼ -7.9% |
| 2022 | 0.12x | CN¥101.66 Million | CN¥74.88 Million | CN¥854.64 Million | ▼ -30.5% |
| 2021 | 0.17x | CN¥133.85 Million | CN¥96.92 Million | CN¥782.23 Million | ▲ +1400.2% |
| 2020 | 0.01x | CN¥10.58 Million | CN¥-20.88 Million | CN¥927.91 Million | ▼ -88.8% |
| 2019 | 0.10x | CN¥88.17 Million | CN¥69.63 Million | CN¥869.43 Million | ▼ -15.9% |
| 2018 | 0.12x | CN¥68.03 Million | CN¥38.44 Million | CN¥564.47 Million | ▼ -53.3% |
| 2017 | 0.26x | CN¥141.17 Million | CN¥40.10 Million | CN¥547.42 Million | ▲ +33.3% |
| 2016 | 0.19x | CN¥92.43 Million | CN¥41.65 Million | CN¥477.74 Million | ▲ +65.0% |
| 2015 | 0.12x | CN¥51.13 Million | CN¥15.44 Million | CN¥435.93 Million | ▼ -63.9% |
| 2014 | 0.32x | CN¥116.39 Million | CN¥82.19 Million | CN¥358.17 Million | ▼ -24.2% |
| 2013 | 0.43x | CN¥138.49 Million | CN¥80.58 Million | CN¥323.21 Million | ▼ -6.2% |
| 2012 | 0.46x | CN¥80.43 Million | CN¥35.05 Million | CN¥175.99 Million | ▼ -21.6% |
| 2011 | 0.58x | CN¥70.78 Million | CN¥4.75 Million | CN¥121.39 Million | ▼ -23.3% |
| 2010 | 0.76x | CN¥99.81 Million | CN¥52.03 Million | CN¥131.25 Million | ▼ -8.5% |
| 2009 | 0.83x | CN¥117.88 Million | CN¥105.55 Million | CN¥141.91 Million | ▲ +354.9% |
| 2008 | -0.33x | CN¥-38.28 Million | CN¥-39.16 Million | CN¥117.45 Million | — |